. Sun Pharmaceutical Industries is expected to report a healthy set of earnings for October-December quarter, driven by strong US business and Halol resolution. One thing to note is numbers will be on low base for the quarter. “The key drivers for the business in terms of ANDA pipeline, differentiated portfolio and ... Read More »